These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 18782775

  • 1. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.
    Cunha SR, Mohler PJ.
    J Biol Chem; 2008 Nov 14; 283(46):31968-80. PubMed ID: 18782775
    [Abstract] [Full Text] [Related]

  • 2. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.
    Bagnato P, Barone V, Giacomello E, Rossi D, Sorrentino V.
    J Cell Biol; 2003 Jan 20; 160(2):245-53. PubMed ID: 12527750
    [Abstract] [Full Text] [Related]

  • 3. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum.
    Armani A, Galli S, Giacomello E, Bagnato P, Barone V, Rossi D, Sorrentino V.
    Exp Cell Res; 2006 Nov 01; 312(18):3546-58. PubMed ID: 16962094
    [Abstract] [Full Text] [Related]

  • 4. Obscurin regulates ankyrin macromolecular complex formation.
    Subramaniam J, Yamankurt G, Cunha SR.
    J Mol Cell Cardiol; 2022 Jul 01; 168():44-57. PubMed ID: 35447147
    [Abstract] [Full Text] [Related]

  • 5. Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover.
    Lange S, Perera S, Teh P, Chen J.
    Mol Biol Cell; 2012 Jul 01; 23(13):2490-504. PubMed ID: 22573887
    [Abstract] [Full Text] [Related]

  • 6. Obscurin is a ligand for small ankyrin 1 in skeletal muscle.
    Kontrogianni-Konstantopoulos A, Jones EM, Van Rossum DB, Bloch RJ.
    Mol Biol Cell; 2003 Mar 01; 14(3):1138-48. PubMed ID: 12631729
    [Abstract] [Full Text] [Related]

  • 7. Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies.
    Busby B, Oashi T, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Mackerell AD, Bloch RJ.
    J Mol Biol; 2011 Apr 29; 408(2):321-34. PubMed ID: 21333652
    [Abstract] [Full Text] [Related]

  • 8. Identification and characterization of two ankyrin-B isoforms in mammalian heart.
    Wu HC, Yamankurt G, Luo J, Subramaniam J, Hashmi SS, Hu H, Cunha SR.
    Cardiovasc Res; 2015 Sep 01; 107(4):466-77. PubMed ID: 26109584
    [Abstract] [Full Text] [Related]

  • 9. Hydrophobic residues in small ankyrin 1 participate in binding to obscurin.
    Willis CD, Oashi T, Busby B, Mackerell AD, Bloch RJ.
    Mol Membr Biol; 2012 Mar 01; 29(2):36-51. PubMed ID: 22416964
    [Abstract] [Full Text] [Related]

  • 10. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system.
    Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S.
    Circ Res; 2001 Nov 23; 89(11):1065-72. PubMed ID: 11717165
    [Abstract] [Full Text] [Related]

  • 11. Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity.
    Randazzo D, Giacomello E, Lorenzini S, Rossi D, Pierantozzi E, Blaauw B, Reggiani C, Lange S, Peter AK, Chen J, Sorrentino V.
    J Cell Biol; 2013 Feb 18; 200(4):523-36. PubMed ID: 23420875
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.
    Bhasin N, Cunha SR, Mudannayake M, Gigena MS, Rogers TB, Mohler PJ.
    Am J Physiol Heart Circ Physiol; 2007 Jul 18; 293(1):H109-19. PubMed ID: 17416611
    [Abstract] [Full Text] [Related]

  • 13. Mapping the binding site on small ankyrin 1 for obscurin.
    Borzok MA, Catino DH, Nicholson JD, Kontrogianni-Konstantopoulos A, Bloch RJ.
    J Biol Chem; 2007 Nov 02; 282(44):32384-96. PubMed ID: 17720975
    [Abstract] [Full Text] [Related]

  • 14. Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.
    Cunha SR, Le Scouarnec S, Schott JJ, Mohler PJ.
    J Mol Cell Cardiol; 2008 Dec 02; 45(6):724-34. PubMed ID: 18790697
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of self-association domains on small ankyrin 1 isoforms.
    Subramaniam J, Yang P, McCarthy MJ, Cunha SR.
    J Mol Cell Cardiol; 2020 Feb 02; 139():225-237. PubMed ID: 32035138
    [Abstract] [Full Text] [Related]

  • 16. Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum.
    Lange S, Ouyang K, Meyer G, Cui L, Cheng H, Lieber RL, Chen J.
    J Cell Sci; 2009 Aug 01; 122(Pt 15):2640-50. PubMed ID: 19584095
    [Abstract] [Full Text] [Related]

  • 17. Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth.
    Borisov AB, Raeker MO, Kontrogianni-Konstantopoulos A, Yang K, Kurnit DM, Bloch RJ, Russell MW.
    Biochem Biophys Res Commun; 2003 Oct 24; 310(3):910-8. PubMed ID: 14550291
    [Abstract] [Full Text] [Related]

  • 18. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly.
    Young P, Ehler E, Gautel M.
    J Cell Biol; 2001 Jul 09; 154(1):123-36. PubMed ID: 11448995
    [Abstract] [Full Text] [Related]

  • 19. Complete human gene structure of obscurin: implications for isoform generation by differential splicing.
    Fukuzawa A, Idowu S, Gautel M.
    J Muscle Res Cell Motil; 2005 Jul 09; 26(6-8):427-34. PubMed ID: 16625316
    [Abstract] [Full Text] [Related]

  • 20. Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart.
    Cunha SR, Mohler PJ.
    Cardiovasc Res; 2006 Jul 01; 71(1):22-9. PubMed ID: 16650839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.